The Doctor’s Advocate | Second Quarter 2013
Director's Forum

PDR+

by David B. Troxel, MD, Medical Director, Board of Governors

Dr. Troxel

The Doctors Company understands that using an electronic health record (EHR) and complying with the changing requirements of Meaningful Use can lead to frustration in a busy medical practice. For this reason, we believe it is important to make you aware of applications that facilitate compliance and are integrated into the EHR workflow.

The Physicians’ Desk Reference, produced by PDRNetwork, is a trusted source of drug information within the medical profession. The Doctors Company (and other medical professional liability insurance companies) works with PDRNetwork through membership in the iHealth Alliance. The iHealth Alliance is an independent not-for-profit organization whose mission is to support and protect the interests of patients and providers as healthcare increasingly adopts electronic systems in patient care. The iHealth Alliance oversees the PDR Drug Alert Network and other safety-related services hosted by PDRNetwork.

In this context, I am pleased to tell you about PDR+, a new app to enhance existing EHR platforms. PDR+, which is available at no cost to providers, facilitates compliance with a Meaningful Use 2 (MU2) requirement that mandates delivery of patient-specific and clinically relevant educational and drug-safety materials directly to patients via the EHR patient portal or print.

In 2013, EHRs must provide this patient education capability in order to be certified by the Office of the National Coordinator for Health Information Technology (ONC). The capability must be infobutton-enabled. An infobutton, which appears in the EHR as a small button or icon (for example, healthcare informatics interoperability), is a healthcare informatics interoperability standard that makes relevant information immediately available to physicians within workflow.

In order to obtain federal EHR incentives, physicians must distribute clinically relevant education and reminders to a minimum of 10 percent of their active patients and use secure messaging to communicate.

The following quotes from MU2 specify the new requirements:

  • Use clinically relevant information from Certified EHRs to identify patient-specific education resources, and provide them to patients.
  • Use secure electronic messaging to communicate with patients on relevant health information.
  • Use clinically relevant information to identify patients who should receive reminders for preventive/follow-up care.

Few, if any, physicians will have the time or resources to develop these educational materials for their patients. Physicians (and other providers) will, however, be responsible for the content of the educational information sent to patients, so it is important that the materials come from trusted sources of high-quality patient education information.

Medical specialty societies are such a source, and many are involved in developing educational materials to satisfy the new MU2 requirement. Third parties may also prepare educational materials, but, if the information is confusing, incorrect, or out-of-date (drug information changes frequently), it may create provider liability. The good news is that patient education has the potential to provide liability protection. Documenting in the EHR when the patient receives patient-specific and disease-specific educational information will contribute to the process of informed consent.

The PDR+ app will appear in EHRs this fall. It will automate the delivery of FDA-approved drug information and reminders sent directly to patients via the EHR patient portal. Because the app is automatically triggered by e-prescribing, it is fully integrated into workflow. PDR+ is designed to improve drug safety and enhance patient compliance, thereby improving both fill rates and adherence. The PDR+ service for EHRs includes PDR-branded drug education programs for more than 2,000 of the most commonly prescribed drugs. There are links to FDA labeling and associated financial assistance programs.

In early 2014, PDR+ will also provide associated disease-specific information that will accompany drug information. PDRNetwork is currently working with leading medical specialty societies to add their patient education programs to this service.


The Doctor’s Advocate is published by The Doctors Company to advise and inform its members about loss prevention and insurance issues.

The guidelines suggested in this newsletter are not rules, do not constitute legal advice, and do not ensure a successful outcome. They attempt to define principles of practice for providing appropriate care. The principles are not inclusive of all proper methods of care nor exclusive of other methods reasonably directed at obtaining the same results.

The ultimate decision regarding the appropriateness of any treatment must be made by each healthcare provider in light of all circumstances prevailing in the individual situation and in accordance with the laws of the jurisdiction in which the care is rendered.

The Doctor’s Advocate is published quarterly by Corporate Communications, The Doctors Company. Letters and articles, to be edited and published at the editor’s discretion, are welcome. The views expressed are those of the letter writer and do not necessarily reflect the opinion or official policy of The Doctors Company. Please sign your letters, and address them to the editor.

See More Issues:

Selecting Your Insurer?
Ask 7 Critical Questions.

Choosing the right medical malpractice insurer is one of the most important decisions you’ll make.
Request our new guide to assist in your research of prospective providers.

Sign up to Receive The Doctor’s Advocate

The Doctor’s Advocate, our quarterly publication, contains timely information on patient safety topics, legislative updates, and the latest industry and company news.